Our Partners: Warren Center for Neuroscience Drug Discovery at Vanderbilt University
Craig Lindsley, Director of the WCNDD talks about the challenges facing neuroscience researchers and the commitment of Boehringer Ingelheim to this important area.
Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide
Brock Reeve, Executive Director of the Harvard Stem Cell Institute, talks about the importance of working together to tackle the challenge of fibrosis.